A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective-Reference-Cited by-同舟云学术

A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective

Published:2015-02 Issue: Volume:417 Page:1-9
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Kloks Cathelijne,Berger Claudia,Cortez Pierre,Dean Yann,Heinrich Julia,Bjerring Jensen Lisbeth,Koppenburg Vera,Kostense Stefan,Kramer Daniel,Spindeldreher Sebastian,Kirby Hishani

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement;Aarden;Curr. Opin. Immunol.,2008

2. Pre-clinical considerations in the assessment of immunogenicity for protein therapeutics;Baker;Curr. Drug Saf.,2010

3. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis;Bartelds;Ann. Rheum. Dis.,2007

4. Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up;Bartelds;JAMA,2011

5. Immunogenicity of microbial digestive enzymes for oral replacement therapy in pancreatic exocrine insufficiency;Berger,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing MAPPs assay as a tool to predict the immunogenicity potential of protein therapeutics;Life Science Alliance;2023-10-13

2. Preclinical risk assessment strategy to mitigate the T-cell dependent immunogenicity of protein biotherapeutics: State of the art, challenges and future perspectives;Journal of Pharmaceutical and Biomedical Analysis;2023-09

3. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development;Cells Tissues Organs;2021-08-11

4. Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside;Journal of Pharmaceutical Sciences;2021-07

5. A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum;Bioanalysis;2021-04